Shareholding disclosure

Credit Suisse Group AG

Declared position

3%

Threshold

Fell below threshold

Timeline

Published

04.01.2014

Transaction

20.12.2013

Voting rights breakdown

Voting rights acquired0%
Voting rights sold0%
Below threshold3%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAE1300010

Beneficial owner

Credit Suisse Group AG

Declared address

Credit Suisse Group AG, 8070 Zürich

Veräusserung im Auftrag der Pharma Strategy Partners AG im Zusammenhang mit dem Kaufangebot der Pharma Strategy Partners an die Aktionäre der Acino Holding AG. Credit Suisse Group AG, indirekt durch deren Tochtergesellschaften Credit Suisse AG, Paradeplatz 8, Postfach, 8070 Zürich, Schweiz, indirekt durch deren Tochtergesellschaften Credit Suisse Holdings (USA) Inc., Eleven Madison Avenue, New York, N.Y. 10010, New York, USA, indirekt durch Credit Suisse (USA) Inc., Eleven Madison Avenue, New York, N.Y. 10010, New York, USA, indirekt durch Credit Suisse Securities (USA) LLC, Eleven Madison Avenue, New York, N.Y. 10010, New York, USA, und Credit Suisse Investments (UK), One Cabot Square, London E14 4QJ, England, indirekt durch Credit Suisse Investment Holdings (UK), One Cabot Square, London E14 4QJ, England, indirekt durch Credit Suisse Securities (Europe) Limited, One Carbot Square, London, E14 4QJ, England.

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open